SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-21-000212
Filing Date
2021-10-12
Accepted
2021-10-12 06:04:12
Documents
20
Period of Report
2021-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20211011.htm   iXBRL 8-K 55466
2 EX-3.1 evfm-31certificateofdesign.htm EX-3.1 162323
3 EX-3.2 evfm-32certificateofdesign.htm EX-3.2 163615
4 EX-10.1 evfm-securitiespurchaseagr.htm EX-10.1 309782
5 EX-99.1 evfm-991pressreleaseannoun.htm EX-99.1 11200
10 image_0a.jpg GRAPHIC 35459
11 imagea.jpg GRAPHIC 36691
12 imageb.jpg GRAPHIC 52679
  Complete submission text file 0001618835-21-000212.txt   1181192

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20211011.xsd EX-101.SCH 2292
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evfm-20211011_def.xml EX-101.DEF 16917
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20211011_lab.xml EX-101.LAB 32731
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20211011_pre.xml EX-101.PRE 17713
13 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20211011_htm.xml XML 14677
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 211316605
SIC: 2834 Pharmaceutical Preparations